Court Opinion

ID: 9392391
Source: CourtListenerOpinion
Date Created: 2023-05-04 18:00:33.773625+00
Date Added: 2024-06-11T17:18:45.736129
License: Public Domain

In the

    United States Court of Appeals
                 For the Seventh Circuit
                     ____________________
No. 22-2247
UNITED STATES OF AMERICA,
                                                   Plaintiff-Appellee,
                                 v.

UZORMA C. IHEDIWA,
                                               Defendant-Appellant.
                     ____________________

         Appeal from the United States District Court for the
                   Eastern District of Wisconsin.
           No. 2:20-CR-00116 — J. P. Stadtmueller, Judge.
                     ____________________

       ARGUED APRIL 4, 2023 — DECIDED MAY 4, 2023
                ____________________

   Before EASTERBROOK, WOOD, and HAMILTON, Circuit
Judges.
   WOOD, Circuit Judge. After a local high school student died
from a fentanyl overdose, the police in Kenosha, Wisconsin,
opened an investigation to track down the source of the fatal
drugs. That investigation led them to Uzorma Ihediwa, who
had sold Percocet pills to the student’s neighbor. Police soon
discovered that Ihediwa’s pills were not authentic Percocet;
2                                                   No. 22-2247

they were counterfeits that contained a mixture of drugs, in-
cluding fentanyl.
    Ihediwa pleaded guilty to one count of distributing fenta-
nyl in violation of 21 U.S.C. § 841(a)(1). The only contested is-
sue at sentencing was whether Ihediwa knew that the pills
contained fentanyl. If so, then his oﬀense level under the U.S.
Sentencing Guidelines would go up four notches. See U.S.S.G.
§ 2D1.1(b)(13). Ihediwa insists that he had no idea that the
pills were counterfeit, much less that they contained fentanyl.
The government, on the other hand, argues that Ihediwa
knew that the pills were fentanyl-laced knock-oﬀs. The dis-
trict court sided with the government. Ihediwa has now ap-
pealed, complaining only about his sentence. Because the dis-
trict court emphasized that its ultimate sentencing decision
was not aﬀected by the Guidelines dispute, any error in its
interpretation of the Guidelines was harmless. We therefore
aﬃrm.
                                I
    Fentanyl is a highly potent drug, and so when the high
school student died of an overdose, the police lost no time in
attempting to track down the source. They learned that the
student’s neighbor, Edward Shingara, had given her the pills
that caused her death. Shingara told police that Ihediwa was
his supplier of “Percocet” pills. Another neighbor, Anthony
Martin, informed police that he too had purchased “Percocet”
pills from Ihediwa. For the next step in the investigation, the
police conducted several controlled purchases of pills from
Ihediwa. They found over 2,000 pills at his residence. But the
recovered pills were not authentic Percocet; they tested posi-
tive for a mixture of drugs, including fentanyl.
No. 22-2247                                                    3

    Ihediwa pleaded guilty to one count of distribution of fen-
tanyl, but he challenged the government’s recommendation
that the district court apply a four-level enhancement under
U.S.S.G. § 2D1.1(b)(13). That enhancement applies “[i]f the de-
fendant knowingly misrepresented or knowingly marketed
as another substance a mixture or substance containing fenta-
nyl.” Ihediwa urged that he did not manufacture the pills
himself, did not know that they were counterfeit, and did not
know that they contained fentanyl.
    The government had no smoking-gun proof that Ihediwa
knew the pills contained fentanyl. It relied instead on circum-
stantial evidence. First, the government argued that Ihediwa
must have known that the pills were fake because they were
brittle, chalky, and easily breakable. It also asserted that Ihe-
diwa was selling the pills for signiﬁcantly less than the esti-
mated street value of authentic Percocet. But even if these
facts demonstrate knowledge that the pills were not real
Percocet, they fall short of showing that the pills contained
fentanyl, as opposed to other substances, let alone that Ihe-
diwa knew their exact composition.
    To ﬁll in that last blank, the government relied heavily on
three text messages Ihediwa received from Bobby Felicelli,
who the government claimed was Ihediwa’s longtime friend
and customer. In the texts, Felicelli said that he had sold some-
one 15 pills, and that the buyer had overdosed because the
pills were not authentic Percocet; instead, they were
“straight” fentanyl. He then asked Ihediwa to call him. The
government argued that Felicelli bought the pills at issue
from Ihediwa, and therefore Ihediwa knew (at least after re-
ceiving the texts) that the pills contained fentanyl. The gov-
ernment also pointed to a recorded phone call between
4                                                  No. 22-2247

Ihediwa and Martin, in which they discussed the high school
student’s then-recent death. Ihediwa said that he “saw that
shit in the paper” and “ain’t trippin’ about it.” But Ihediwa
and Martin did not mention fentanyl in the conversation, and
the news that the student had overdosed on fentanyl speciﬁ-
cally was not yet public. The government nevertheless argued
that Ihediwa’s response reveals that he was aware of the dan-
gerousness of his pills. Even if this is a reasonable inference,
however, fentanyl is not the only substance that can make
pills dangerous.
    The district court held that the enhancement applied. It
ﬁrst explained that the word “knowingly” in the Guideline
could include deliberately avoiding knowledge of an inculpa-
tory fact. “[W]hat’s driving this case along,” the court ex-
plained, “[is] what is expected in terms of a reasonable person
confronted under similar circumstances with this whole no-
tion of knowingly … . [W]e can’t go forward with what might
reasonably be described as the ostrich with the head in the
sand approach.” The court then found that there were “mul-
tiple red ﬂags” and “an abundance of notice and from multi-
ple vantage points” that would have put a reasonable person
“on notice that not all was well.” The court then jumped to the
conclusion that Ihediwa was deliberately avoiding awareness
of the fentanyl and that this behavior satisﬁed the knowledge
requirement of the enhancement.
   The enhancement increased Ihediwa’s Guidelines-recom-
mended range from 51–63 months to 78–97 months. But the
court ultimately sentenced Ihediwa to 40 months’ imprison-
ment—a surprisingly low sentence that was below even the
one the Guidelines would have recommended without the
disputed enhancement. Ihediwa appeals, arguing that the
No. 22-2247                                                   5

district court committed procedural error by misstating and
then misapplying the legal standard for knowledge.
                               II
    To determine whether a Guidelines enhancement was cor-
rectly imposed, we review the district court’s legal conclu-
sions de novo and its factual ﬁndings for clear error. United
States v. Major, 33 F.4th 370, 378 (7th Cir. 2022).
     The Guidelines do not speciﬁcally deﬁne “knowledge” or
“knowingly,” and so we assume that these terms have their
“usual meaning.” United States v. Bader, 956 F.2d 708, 710 (7th
Cir. 1992). “For purposes of criminal liability, deliberately
avoiding knowledge of a criminal activity is the same thing as
having actual knowledge of that activity.” United States v. Car-
rillo, 435 F.3d 767, 780 (7th Cir. 2006). This standard is a de-
manding one; negligence or recklessness will not suﬃce.
United States v. Tantchev, 916 F.3d 645, 653 (7th Cir. 2019).
   The district court made numerous references to “a reason-
able person” and “notice” throughout its analysis of whether
the enhancement applied to Ihediwa. This raises the question
whether the court appreciated the critical distinction between
deliberate avoidance and mere recklessness or negligence.
But we need not decide whether the court correctly held that
Ihediwa had actual or constructive knowledge that his pills
contained fentanyl. The court made clear that the contested
enhancement did not factor into its ultimate sentencing deci-
sion. Therefore, any error was harmless.
    “[W]e have often encouraged district judges facing a
tricky guideline issue to ask themselves whether the answer
actually makes a difference to them.” United States v. White,
883 F.3d 983, 987 (7th Cir. 2018). This does not mean that a
6                                                  No. 22-2247

district court can inoculate every Guidelines miscalculation
with a boilerplate disclaimer that its final decision would be
the same regardless of any error. But when the district court
credibly and thoroughly “explains that a disputed guidelines
issue ultimately did not matter for the exercise of sentencing
discretion under [18 U.S.C.] § 3553(a), we will treat an argua-
ble error in the guideline calculation as harmless.” Id.; accord
United States v. Abbas, 560 F.3d 660, 667 (7th Cir. 2009) (hold-
ing that a Guidelines error was harmless because the district
court provided “a detailed explanation of the basis for the
[chosen sentence]” as opposed to “just a conclusory comment
tossed in for good measure”).
    Here, the district court said several times that “the record
should be crystal clear that the sentence imposed by the Court
would be the same irrespective of whether either guidelines
construct applied, and that is underscored by the serious na-
ture of the conduct here.” This was not a rote disclaimer. The
court provided an adequate explanation of why its sentencing
decision was unaﬀected by the disputed “knowledge” en-
hancement. Throughout the sentencing hearing, the court
made clear that it disapproved of Ihediwa’s reckless conduct,
regardless of whether his actions met the demanding “delib-
erate avoidance” standard needed to constitute knowledge.
In its view,
       Mr. Ihediwa was on very, very, very troubled
       waters with his continued distribution of this
       substance marketed as Percocet because there
       are multiple red ﬂags here … . [T]here’s appro-
       priate notice, and there’s an abundance of notice
       from multiple vantage points, whether it’s the
       structure of the substance, whether it’s the
No. 22-2247                                                     7

       price, whether it’s fragility of the pills, et cetera,
       et cetera. … Whether [the text messages] are
       true or ﬁction, they put [Ihediwa] on notice that
       all was not well. That’s what this is all about.
In short, the court determined that the “salient fact” was that
Ihediwa was “on notice” about the dangerousness of the pills
and nevertheless continued to distribute them. The court also
explained that it gave weight to the mitigating factors pre-
sented by the defense, including Ihediwa’s academic achieve-
ments during the pendency of the case.
    These considerations were entirely appropriate. See 18
U.S.C. § 3553(a)(1) (“the nature and circumstances of the of-
fense and the history and characteristics of the defendant”);
§ 3553(a)(2)(A) (“the need for the sentence imposed … to re-
ﬂect the seriousness of the oﬀense”). Although the Guidelines
enhancement at issue required the district court to thread the
needle between recklessness and knowledge, the court was
within its authority to decline to attach punitive signiﬁcance
to that distinction. Courts are “entitled to adopt their own
sentencing philosophy based in the considerations of section
3553(a), and so they are not compelled to accept the advice
that the guidelines oﬀer.” United States v. Bravo, 26 F.4th 387,
396 (7th Cir. 2022).
   The fact that the district court’s choice of sentence was not
aﬀected by the Guidelines dispute is further supported by the
sentence itself: only 40 months’ imprisonment. This sentence
was well below the Guidelines-recommended range, whether
with the enhancement (78–97 months) or without it (51–63
months).
8                                                 No. 22-2247

   Because the district court selected a sentence for Ihediwa
based on reasons independent of the disputed enhancement,
and it supported its choice using the section 3553(a) factors,
any error in its application of U.S.S.G. § 2D1.1(b)(13) was
harmless.
                             III
    Because the alleged procedural error was harmless and
Ihediwa does not challenge the substantive reasonableness of
his sentence, we AFFIRM the judgment of the district court.